IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1330.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 18-May-2015
Nature Methods
Microchip captures clusters of circulating tumor cells -- NIH study
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads. The work was funded by the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health.
NIH/National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

Contact: Margot Kern
NIH/National Institute of Biomedical Imaging & Bioengineering

Public Release: 18-May-2015
Nature Immunology
UCSF-led study explains how early childhood vaccination reduces leukemia risk
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia, the most common type of childhood cancer.
National Institutes of Health, NIH/National Cancer Institute, Leukemia and Lymphoma Society, William Lawrence and Blanche Hughes Foundation, California Institute for Regenerative Medicine, Wellcome Trust, Cancer Research UK

Contact: Juliana Bunim
University of California - San Francisco

Public Release: 18-May-2015
Nature Methods
New device successfully captures metastasis-associated circulating tumor cell clusters
The latest version of a microfluidic device for capturing rare circulating tumor cells (CTCs) is the first designed specifically to capture clusters of two or more cells, rather than single cells. These CTC clusters appear gnificantly more likely to cause metastases than single circulating tumor cells.
National Institutes of Health, NIH/National Institute of Biomedical Imaging and Bioengineering, Stand Up to Cancer, Howard Hughes Medical Institute, Prostate Cancer Foundation, Charles Evans Foundation, Johnson and Johnson

Contact: Katie Marquedant
Massachusetts General Hospital

Public Release: 18-May-2015
Annals of Internal Medicine
Not all women with dense breasts need more imaging; ACP advises 'smarter' cancer screening
Not all women with dense breasts are at high enough risk for breast cancer to justify additional imaging after a normal mammogram, according to a study published in Annals of Internal Medicine. Women with specific types of dense breasts who also have a high five-year cancer risk should discuss supplemental screening strategies with their doctors.

Contact: Angela Collom
American College of Physicians

Public Release: 18-May-2015
Annals of Internal Medicine
ACP releases High Value Care screening advice for 5 common cancers
In a paper published in Annals of Internal Medicine, the American College of Physicians issued advice for screening average risk adults without symptoms for five common cancers: breast, colorectal, ovarian, prostate, and cervical. In a companion piece also published in Annals, ACP outlined a framework for thinking about the value of varying intensities of cancer screening.

Contact: Steve Majewski
American College of Physicians

Public Release: 18-May-2015
Digestive Disease Week
Study finds non-invasive colon cancer screening may be promising for African-Americans
In a first-of-its-kind clinical trial, physician-scientists at University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine found that a new non-invasive technology for colon cancer screening is a promising alternative to colonoscopy for African-Americans. The study recruited patients to compare the effectiveness of stool DNA testing with colonoscopy for detecting large colon polyps.
NIH/National Cancer Institute

Contact: Alicia Reale
University Hospitals Case Medical Center

Public Release: 18-May-2015
European Physical Journal D
Organic nanoparticles, more lethal to tumors
Radiotherapy used in cancer treatment is a promising treatment method, albeit rather indiscriminate. Indeed, it affects neighboring healthy tissues and tumors alike. Researchers have thus been exploring the possibilities of using various radio-sensitizers; these nanoscale entities focus the destructive effects of radiotherapy more specifically on tumor cells. In a study published in EPJ D, physicists have shown that the production of low-energy electrons by radio-sensitizers made of carbon nanostructures hinges on a key physical mechanism referred to as plasmons.

Contact: Sabine Lehr

Public Release: 18-May-2015
Digestive Disease Week
Researchers make progress engineering digestive system tissues
New proof-of-concept research suggests the potential for engineering replacement intestine tissue in the lab, a treatment that could be applied to infants born with a short bowel and adults having large pieces of gut removed due to cancer or inflammatory bowel disease.

Contact: Karen Richardson
Wake Forest Baptist Medical Center

Public Release: 18-May-2015
Nature Methods
Research community comes together to provide new 'gold standard' for genomic data analysis
Cancer research leaders at the Ontario Institute for Cancer Research, Oregon Health & Science University, Sage Bionetworks, the distributed DREAM community and The University of California Santa Cruz published the first findings of the ICGC-TCGA-DREAM Somatic Mutation Calling Challenge today in the journal Nature Methods.

Contact: Christopher Needles
Ontario Institute for Cancer Research

Public Release: 18-May-2015
EMBO Molecular Medicine
A blood test for early detection of breast cancer metastasis
Research findings from Lund University in Sweden now provide new hope for a way of detecting metastases significantly earlier than is currently possible.
Swedish Cancer Society, Swedish Research Council, Swedish Foundation for Strategic Research, Knut and Alice Wallenberg Foundation, VINNOVA, National Health Service and others

Contact: Lao Saal, M.D., Ph.D.
Lund University

Public Release: 18-May-2015
Annals of Oncology
Researchers quantify proportion of different genetic mutations in individual bowel cancers
A study published in the leading cancer journal Annals of Oncology has, for the first time, quantified the different mutational profiles of clusters of cells in individual tumors in patients with bowel cancer that has spread to other parts of the body. The research could have important consequences on the efficacy of therapies: in these 'mixed' tumors, some tumor cell clusters might be sensitive to a targeted therapy while others are resistant.
Associazione Italiana per la Ricerca sul Cancro

Contact: Emma Mason
European Society for Medical Oncology

Public Release: 18-May-2015
European Urology
Urine-based test improves on PSA for detecting prostate cancer
A new urine-based test improved prostate cancer detection -- including detecting more aggressive forms of prostate cancer -- compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
Hologic/Gen-Probe Inc., Early Detection Research Network, National Institutes of Health, Prostate Cancer Foundation, A. Alfred Taubman Medical Research Institute, Doris Duke Foundation, American Cancer Society

Contact: Nicole Fawcett
University of Michigan Health System

Public Release: 17-May-2015
American Thoracic Society
New England Journal of Medicine
Study validates effectiveness of genomic test for lung cancer detection
A new test co-developed by a Boston University School of Medicine researcher will allow patients suspected of having lung cancer to be subjected to fewer and less-invasive tests to determine if they have the disease.
Allegro Diagnostics Corp., National Institutes of Health, NIH/National Cancer Institute

Contact: Gina DiGravio
Boston University Medical Center

Public Release: 15-May-2015
Scientific Reports
New screening method for prostate cancer recurrence
Researchers in the Quantitative Light Imaging Laboratory at the Beckman Institute for Advanced Science and Technology at the University of Illinois used spatial light interference microscopy in order to identify patients at higher risk for prostate cancer recurrence.
National Science Foundation, Agilent Laboratories

Contact: Maeve Reilly
Beckman Institute for Advanced Science and Technology

Public Release: 15-May-2015
Cancer Epidemiology, Biomarkers & Prevention
Cancer survivors have evolving information needs
Judging by the nature and topics of their information seeking, cancer patients' information needs appear to differ depending on the type of cancer they have and where they are in their survivorship.
NIH/National Cancer Institute, NIH/Eunice Kennedy Shriver National Institutes of Child Health and Human Development, University of Minnesota Deborah E. Powell Center for Women's Health

Contact: Jacquie Posey
University of Pennsylvania Annenberg School for Communication

Public Release: 15-May-2015
American Urological Association 2015 Annual Meeting
Fee-for-service health care may lead to higher risk for robotic prostate surgery patients
A 'perverse disincentive' for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led by Henry Ford Hospital researchers.

Contact: Tammy Battaglia
Henry Ford Health System

Public Release: 15-May-2015
American Urological Association 2015 Annual Meeting
Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer
Myriad presented clinical data for its Prolaris test at the 2015 American Urological Association Annual Meeting that showed the significant ability of the Prolaris test to help physicians improve care for men diagnosed with prostate cancer. New clinical validation data were presented that establish an active surveillance (AS) threshold for men with localized prostate cancer. The AS threshold is a composite of the Prolaris test score and clinicopathologic features.

Contact: Ron Rogers
Myriad Genetics, Inc.

Public Release: 14-May-2015
American Society of Clinical Oncology (ASCO)
Experimental immunotherapy shows high response rate in advanced lung cancer
An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer.

Contact: Karen Teber
Georgetown University Medical Center

Public Release: 14-May-2015
Cancer Research
Contraceptive and cholesterol-lowering drugs used to treat cancer
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.

Contact: Luke Harrison
University of Birmingham

Public Release: 14-May-2015
JAMA Oncology
Smoking induces early signs of cancer in cheek swabs
DNA damage caused by smoking can be detected in cheek swabs, finds research published today in JAMA Oncology. The study provides evidence that smoking induces a general cancer program that is also present in cancers which aren't usually associated with it -- including breast and gynecological cancers.
Eve Appeal

Contact: Wesley Hutchins
University College London

Public Release: 14-May-2015
Frontiers in Neurology
Geneticists clock genetic differences between 'larks' and 'owls'
A new study from University of Leicester uncovers clues for 'morningness' and 'eveningness.'
Biotechnology and Biological Sciences Research Council

Contact: Dr Eran Tauber (PhD)
University of Leicester

Public Release: 14-May-2015
Cancer Research
Revealing kidney cancer's secret
An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma reprograms its metabolism and evades the immune system.
National Institutes of Health, US Department of Veterans' Affairs, LLNL-UCDCC Fitzpatrick Award, Paula Moss Trust, J. Randall and Kathleen L. MacDonald Research Fund

Contact: Dorsey Griffith
University of California - Davis Health System

Public Release: 14-May-2015
American Journal of Public Health
Campaign increases mouth and throat cancer screenings among low-income rural Floridians
Raising awareness of the dangers of mouth and throat cancer increased the number of black men in some of Florida's poorest counties who sought screening for the first time, opening the door to improved survival rates through early detection and treatment, UF Health researchers report.

Contact: Elizabeth Hillaker-Downs
University of Florida

Public Release: 14-May-2015
Proceedings of the National Academy of Sciences
Georgia State research paves way for early detection of liver cancer
Led by Georgia State University, researchers have developed the first robust and noninvasive detection of early stage liver cancer and liver metastases, in addition to other liver diseases, such as cirrhosis and liver fibrosis.
National Institutes of Health

Contact: Brian Mullen
Georgia State University

Public Release: 14-May-2015
Unemployment linked to rise in prostate cancer deaths
The knock-on effects of the economic downturn have been explored in economy and psychology. Now researchers are examining the effects of unemployment on an even darker subject -- cancer mortality. One would think that dealing with unemployment was challenge enough. But according to the latest research published in ecancermedicalscience, rises in unemployment are associated with significant increases in prostate cancer mortality.

Contact: Audrey Nailor

Showing releases 76-100 out of 1330.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

  Search News Releases